CDTX vs MAS · rev $1.3M vs P/E 18, rev $7.83B
Cidara Therapeutics Inc (CDTX) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
CDTX currently screens at market cap $6.96B. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the CDTX and MAS stock pages for the full models.
Not investment advice.